Precision medicine for gastrointestinal cancers: a conference report

• Type of Material: Article
• Authors: Ibrahim Halil Sahin, Emory University
• Language: English
• Date: 2020-07-01
• Publisher: Future Science
• Publication Version: Final Published Version
• Copyright Statement: © 2020 Ibrahim Sahin.
• License: Creative Commons Attribution 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.2144/fsoa-2020-0061
• Title of Journal or Parent Work: Future Science OA
• Volume: 6
• Issue: 6
• Grant/Funding Information: None declared
• Keywords: gastrointestinal cancers; pancreatic cancer; hepatocellular carcinoma; immunotherapy; colorectal cancer; precision medicine; cholangiocarcinoma; IDH mutations; gastric cancer
• Research Categories: Biology, Cell; Health Sciences, Immunology; Health Sciences, Rehabilitation and Therapy; Health Sciences, Oncology

Abstract

As cancer management evolves into precision medicine national/international cancer meetings bring novel therapeutic approaches and potentially practice-changing results of clinical studies are presented. This year, the ASCO GI Symposium 2020 had also several updates from ongoing and finalized clinical trials. Although there were no groundbreaking results that impact the daily practice directly, several highly important data from ongoing studies were shared with the audience. In this report, the highlights of the ASCO GI Symposium 2020 are presented with a future perspective.